Vulnerability Description
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
CVSS Score
HIGH
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Philips | Intellispace Cardiovascular | <= 3.1 |
| Philips | Xcelera | <= 4.1 |
Related Weaknesses (CWE)
References
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01Third Party AdvisoryUS Government Resource
- https://www.usa.philips.com/healthcare/about/customer-support/product-securityVendor Advisory
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01Third Party AdvisoryUS Government Resource
- https://www.usa.philips.com/healthcare/about/customer-support/product-securityVendor Advisory
FAQ
What is CVE-2018-14787?
CVE-2018-14787 is a vulnerability with a CVSS score of 7.8 (HIGH). In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executabl...
How severe is CVE-2018-14787?
CVE-2018-14787 has been rated HIGH with a CVSS base score of 7.8/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2018-14787?
Check the references section above for vendor advisories and patch information. Affected products include: Philips Intellispace Cardiovascular, Philips Xcelera.